@article{JSFS_2004__145_3_15_0, author = {Micallef, Sandrine and Bois, Fr\'ed\'eric Yves}, title = {Applications des mod\`eles physiologiques \`a l'analyse de donn\'ees de toxicocin\'etique}, journal = {Journal de la Soci\'et\'e fran\c{c}aise de statistique}, pages = {15--32}, publisher = {Soci\'et\'e fran\c{c}aise de statistique}, volume = {145}, number = {3}, year = {2004}, language = {fr}, url = {http://www.numdam.org/item/JSFS_2004__145_3_15_0/} }
TY - JOUR AU - Micallef, Sandrine AU - Bois, Frédéric Yves TI - Applications des modèles physiologiques à l'analyse de données de toxicocinétique JO - Journal de la Société française de statistique PY - 2004 SP - 15 EP - 32 VL - 145 IS - 3 PB - Société française de statistique UR - http://www.numdam.org/item/JSFS_2004__145_3_15_0/ LA - fr ID - JSFS_2004__145_3_15_0 ER -
%0 Journal Article %A Micallef, Sandrine %A Bois, Frédéric Yves %T Applications des modèles physiologiques à l'analyse de données de toxicocinétique %J Journal de la Société française de statistique %D 2004 %P 15-32 %V 145 %N 3 %I Société française de statistique %U http://www.numdam.org/item/JSFS_2004__145_3_15_0/ %G fr %F JSFS_2004__145_3_15_0
Micallef, Sandrine; Bois, Frédéric Yves. Applications des modèles physiologiques à l'analyse de données de toxicocinétique. Journal de la Société française de statistique, Volume 145 (2004) no. 3, pp. 15-32. http://www.numdam.org/item/JSFS_2004__145_3_15_0/
Population pharmacokinetics. International Journal of Clinical Pharmacology, Therapy, and Toxicology 30, 520-522.
(1992).Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment. Toxicology Letters 79, 35-44.
(1995).Reference Physiological Parameters in Pharmacokinetics modelling.
and (1988).An introduction to the use of physiologically based pharmacokinetic models in risk assessment. Statistical Methods in Medical Research 6, 341-358.
and (1997).Physiological pharmacokinetic modelling. Xenobiotica 20, 1241-1257.
and (1990).Bayesian Theory. New York, Wiley. | MR | Zbl
and (1994).Traitement bayesien des incertitudes. Paris, Lavoisier.
, and (2000).Modélisation toxicocinétique de la concentration de 2,3,7,8-tetrachloro-p-dioxine après ingestion chez la femme. Environnement, Risques et Santé 2(1), 45-53.
(2003).Population toxicokinetics of tetrachloroethylene. Archives of Toxicology 70(6), 347-355.
, , , et al (1996).Population toxicokinetics of benzene. Environmental Health Perspectives 104 (suppl. 6), 1405-1411.
, , , et al (1996).MCSim : a simulation program. Journal of Statistical Software 2(9), http://toxi.ineris.fr/activites/toxicologie_quantitative/mcsim/mcsim.php.
and (1997).Optimal design for a study of butadiene toxicokinetics in humans. Toxicological Sciences : an Official Journal of the Society of Toxicology 49(2), 213-224.
, , , et al (1999).Physiological parameter values for physiologically based pharmacokinetic models. Toxicology and Industrial Health 13(4), 407-484.
, , , et al (1997).Nonparametric density estimation applied to population pharmacokinetics. Math. Biosci. 133(1), 51-68. | Zbl
and (1996).Biological basis for extrapolation across mammalian species. Regulatory Toxicology and Pharmacology 6, 211-237.
, and (1986).Physiological parameters in laboratory animals and humans. Pharmaceutical Research 10, 1093-1095.
and (1993).Physiological pharmacokinetic analysis using population modeling and informative prior distributions. Journal of the American Statistical Association 91, 1400-1412. | Zbl
, and (1996).Bayesian Data Analysis. London, Chapman & Hall. | MR | Zbl
, , , et al (1995).Physiologically based pharmacokinetic modelling : principles and applications. Journal of Pharmaceutical Sciences 72, 1103-1127.
and (1983).Markov Chain Monte Carlo in Practice. London, Chapman & Hall. | MR | Zbl
, and (1996).Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment. Risk Analysis : an Official Publication of the Society for Risk Analysis 21(4), 579-583.
(2001).Monte Carlo Methods. London, Chapman and Hall. | MR | Zbl
and (1964).On the dangers of adjusting the parameter values of mechanism-based mathematical models. Journal of Theoretical Biology 183, 417-427.
and (1996).Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20, 1201-1231.
(1990).International Commission on Radiological Protection (ICRP) (2003). Basic Anatomical and Physiological Data for Use in Radiological Protection : Reference Values. Stockholm, .
Species differences in the production and clearance of 1,3-butadiene metabolites : a mechanistic model indicates predominantly physiological, not biochemical, control. Carcinogenesis 14(4), 619-628.
and (1993).Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates. Toxicology 113(1-3), 31-39.
and (1996).A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment. Chemosphere 35(3), 427-452.
and (1997).Assessing, accommodating, and interpreting the influences of heterogeneity. Environmental Health Perspectives 90, 215-222.
(1991).A computer model and program for xenobiotic disposition during pregnancy. Computer Methods and Programs in Biomedicine 53(3), 201-224.
, , , et al (1997).A Bayesian compartmental model for the evaluation of 1,3-butadiene metabolism. Journal of the Royal Statistical Society, Series C-Applied Statistics 52, 291-305. | MR | Zbl
, , , et al (2003).Pharmacokinetics, pharmacodynamics, and prediction of developmental abnormalities. Reproductive Toxicology 11(2-3) : 413-416.
(1997).Population models. Statistical Methodology in the Pharmaceutical Sciences. D. A. Berry, New York, Marcel Dekker, Inc., 139-162.
and (1990).Statistical methods for population pharmacokinetic modelling. Statist. Methods Med. Res. 7(1), 63-84.
and (1998).Méthodes de Monte Carlo par Chaînes de Markov. Paris, Economica. | MR | Zbl
(1996).Clinical Pharmacokinetics : Concepts and Applications. Philadelphia, Lea &, Febiger.
and (1989).The population approach to pharmacokinetic data analysis : rationale and standard data analysis methods. Drug Metabolism Reviews 15, 153-171.
(1984).Bayesian individualization of pharmacokinetics : simple implementation and comparison with non-Bayesian methods. Journal of Pharmaceutical Sciences 7 1 , 1344-1348.
and (1982).Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations. Toxicological Sciences 62(1), 124-139.
, , , et al. (2001).A generic toxicokinetic model for persistent lipophilic compounds in humans : an application to TCDD. Fundamental and Applied Toxicology 31, 83-94.
, and (1996).The Bayesian modeling of covariates for population pharmacokinetic models. Journal of the American Statistical Association 91, 917-927. | Zbl
and (1996).Bayesian nonparametric population models : formulation and comparison with likelihood approaches. Journal of Pharmacokinetics and Biopharmaceutics 25(2), 235-53.
and (1997).Extrapolation of a PBPK model for dioxins across dosage regimen, gender, strain, and species. Toxicological Sciences 56, 49-60.
, , , et al. (2000).Interspecies extrapolation of physiological pharmacokinetic parameter distributions. Risk Analysis : an Official Publication of the Society for Risk Analysis 16(6) : 741-754.
and (1996).